Two peptides predict cardiomyopathy after brain haemorrhage
Swedish PhD student finds biomarkers that can identify subarachnoid haemorrhage patients at risk of cardiomyopathy.
Source: Alfred Pasieka / Science Photo Library
Patients with subarachnoid haemorrhage (SAH) – a type of stroke – are at risk of developing stress-induced cardiomyopathy (SIC), a condition in which the left ventricle of the heart becomes inactive.
Research from the University of Gothenburg, Sweden, has identified two biomarkers that could predict patients most at risk.
PhD student Jonatan Oras studied 112 patients admitted to intensive care with SAH, of whom 25 developed SIC. Oras found that these patients had higher peak levels of the cardiac damage peptides hsTnT and NTproBNP. One to three days after onset of SIC, levels of these peptides were superior for predicting SIC than both ECG and X-ray.
In animal models of SAH, Oras found that the anaesthetic isoflurane had a cardioprotective effect against the development of SIC. He suggests further research is conducted into isoflurane sedation for patients with SAH.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20200198
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00Buy now
FASTtrack: Pharmaceutical Compounding and Dispensing helps the student compounder to understand the key dosage forms in extemporaneous dispensing.£25.00Buy now